Clicky

Solid Biosciences Inc.(SLDB)

Description: Solid Biosciences Inc is a life science company engaged in developing therapies for Duchenne muscular dystrophy. Its product candidate, SGT-001, is a gene transfer under development to restore functional dystrophin protein expression in patients' muscles.


Keywords: Dystrophy Muscular Dystrophy Duchenne Muscular Dystrophy Duchenne Dystrophin Cytoskeleton

Home Page: www.solidbio.com

SLDB Technical Analysis

141 Portland Street
Cambridge, MA 02139
United States
Phone: 617 337 4680


Officers

Name Title
Mr. Ian F. Smith A.C.A., ACA, C.P.A., CPA Exec. Chair
Mr. Ilan Ganot Co-founder, Strategic Advisor to the CEO & Director
Mr. Matthew Bennett Arnold Co-Founder & Board Member
Mr. Alexander G. Cumbo Pres, CEO & Director
Mr. Gilad David Hayeem Co-Founder
Ms. Annie Ganot Co-Founder & Head of Patient Advocacy
Dr. Andrey Juan Zarur Ph.D. Co-Founder
Mr. Stephen J. Di Palma M.B.A, M.B.A. Interim CFO, Treasurer & Principal Accounting Officer
Mr. Paul Herzich Chief Technology Officer
Mr. David Tyronne Howton Jr., J.D. Chief Admin. Officer

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0.9036
Price-to-Sales TTM: 11.8924
IPO Date: 2018-01-26
Fiscal Year End: December
Full Time Employees: 104
Back to stocks